iRhythm Technologies International

iRhythm Technologies International is a digital healthcare company focused on cardiac monitoring and arrhythmia diagnosis. The company develops advanced wearable biosensor technology, cloud-based data analytics, and proprietary AI algorithms to enhance the detection and prevention of cardiac diseases. Its mission is to improve health outcomes through earlier and more accurate diagnoses of cardiac arrhythmias. The core product platform, Zio by iRhythm, includes the Zio Monitor System for continuous ECG monitoring, Zio AT for real-time cardiac telemetry, and ZioSuite, a web portal and mobile app for healthcare providers. The MyZio Patient App allows patients to log symptoms and access educational content, promoting engagement and compliance. iRhythm's FDA-cleared technology features a deep-learned AI algorithm that matches expert cardiologists in accuracy, analyzing extensive heartbeat data to produce reliable reports. Headquartered in San Francisco, iRhythm serves a wide range of healthcare professionals, including cardiologists and neurologists, through a dedicated network of sales and support teams. The company is publicly traded on Nasdaq under the ticker IRTC and is committed to innovation and patient-centered solutions in cardiac care.

• Employees 62
• Founded 2006